Our immunodiagnostics core components enable high-sensitivity chemiluminescence (CLIA), lateral flow assay (LFA), and automated ELISA platforms, providing ISO13485-certified recombinant antigens, monoclonal/polyclonal antibodies, and functionalized magnetic/colorimetric nano-engineered microspheres with ≤5% inter-lot variability for quantitative assay development.

Leveraging proprietary antibody humanization and high-density conjugation technologies, we provide tailored immunoreagent development including matched antibody pairs(<1.0% cross-reactivity), IVD-grade calibrators and controls traceable to WHO/NIBSC standards, HRP/ALP/fluorescence-conjugated detection reagents optimized for 10⁶:1 signal-to-noise ratios, and blocking buffer achieving low nonspecific binding(<0.5 OD in heterophilic serum).